Key result
A planar parallel wire robot successfully deployed through a subxiphoid incision, adhered to the beating heart, and performed myocardial injections in vivo.
A novel parallel wire robot demonstrates feasibility for minimally invasive epicardial interventions on a beating heart without requiring mechanical stabilization or lung deflation.
Supports preclinical feasibility of robotic epicardial injections; hypothesis-generating, human translation unproven.
This paper describes the design and preliminary testing of a planar parallel wire robot that adheres to the surface of the beating heart and provides a stable platform for minimally invasive epicardial therapies. The device is deployed through a small subxiphoid skin incision and attaches to the heart using suction. This methodology obviates mechanical stabilization and lung deflation, which are typically required during minimally invasive beating-heart surgery. The prototype design involves three vacuum chambers connected by two flexible arms. The chambers adhere to the epicardium, forming the vertices of a triangular base structure. Three cables connect a movable end-effector head to the three bases; the cables then pass out of the body to external actuators. The surgical tool moves within the triangular workspace to perform injections, ablation, or other tasks on the beating heart. Tests in vitro and in vivo were conducted to demonstrate the capabilities of the system. Tests in vivo successfully demonstrated the ability to deploy through a subxiphoid incision, adhere to the surface of the beating heart, move the surgical tool head within the robot's workspace, and perform injections into the myocardium.
No takes yet. Share an insight, caveat, or question.
Costanza et al. (2014) studied Minimally invasive epicardial therapies. Planar parallel wire robot was evaluated on Device deployment, adherence, movement, and injection capability. A planar parallel wire robot successfully deployed through a subxiphoid incision, adhered to the beating heart, and performed myocardial injections in vivo.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: